International Deals

My time has been spent in ?Europe.? In the last two days, I have been to Italy four times, London and France each twice and made brief stops in Germany and Switzerland. The series of meetings that I have had with European companies has caused me to come to the conclusion that companies in that region are undervalued, undermanaged, underappreciated and unhappy with the lack of availabe capital. The companies are therefore looking to gain additional investor support from US venture capitalists. At

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
My time has been spent in ?Europe.? In the last two days, I have been to Italy four times, London and France each twice and made brief stops in Germany and Switzerland. The series of meetings that I have had with European companies has caused me to come to the conclusion that companies in that region are undervalued, undermanaged, underappreciated and unhappy with the lack of availabe capital. The companies are therefore looking to gain additional investor support from US venture capitalists. At the same time, European venture capitalists are expressing concern with the inability to find local IPO exits for many of their companies and are looking to the US to find better investees. Anonymous Quote of the Day: ?A good biotech CEO is like a bullfighter: he possesses agility, grace, courage to stare danger in the face and only the remote prospect of being paid well if he survives.?
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Justin Silver

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio